Tradestie Institutional Equity Comparison Engine

VOR vs VNDA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VOR Overall Edge

VOR Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vor Biopharma Inc. Common Stock (VOR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while VNDA counters with relative strength in Valuation. Fundamentally, VOR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VNDA at 103.1x Forward P/E and -77.6% operating margin (+24.1% YoY). In options structure, VOR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against VNDA sits in BREAKDOWN (75th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VNDA
VOR N/M vs VNDA 103.1x Fwd P/E
Growth & Margin Winner VOR
Op Margin 0.0% vs -77.6% ยท YoY +0.0% vs +24.1%
Momentum & Technical Winner VOR
1Y +97.5% vs -12.6% ยท 52W Pos 65% vs 4%
Options & Structure Winner VOR
CONSOLIDATION (6th %ile IV) vs BREAKDOWN (75th %ile IV)
VOR NASDAQ
Vor Biopharma Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$19.26
-0.82% 1D
Market Cap $1.2B
1M Return +6.82%
1Y Return +97.54%
Forward P/E N/M
Unified AI Score
57.8 / 100 HOLD
Tech 50.0 Fund 55.0 Flow 66.0 Mom 50.0
VNDA NASDAQ
Vanda Pharmaceuticals Inc.
Pharmaceutical Preparations
$3.79
-4.89% 1D
Market Cap $238.9M
1M Return -5.83%
1Y Return -12.56%
Forward P/E 103.1x
Unified AI Score
49.0 / 100 HOLD
Tech 56.0 Fund 58.0 Flow 65.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VOR +97.54% VNDA -12.56% Spread: +110.1 pp (VOR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VOR TTM Op. Margin: 0.0% VNDA TTM Op. Margin: -77.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VOR vs VNDA. Trailing 12-month operating profitability (VOR 0.0% vs VNDA -77.6%) and valuation multiples (VOR N/M vs VNDA 103.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VOR (7) vs VNDA (3)
Institutional Metric VOR VNDA Criterion Row Winner
Market Capitalization Scale $1.2B $238.9M Larger Scale VOR
Trailing P/E Ratio Valuation 0.1x 103.1x Lower Multiple VOR
Forward P/E Ratio Valuation N/M 103.1x Lower Multiple VNDA
Revenue Growth (YoY) Growth +0.0% +24.1% Higher Growth VNDA
Operating Margin (TTM) Profitability 0.0% -77.6% Higher Margin VOR
Net Profit Margin Profitability 0.0% -119.9% Higher Margin VOR
Return on Equity (ROE) Capital Efficiency -125.4% -82.5% Higher ROE VNDA
52-Week Range Position Momentum 65% ($6โ€“$26) 4% ($4โ€“$10) Stronger Trend VOR
Beta / 30D Volatility Risk Regime 1.91ฮฒ ยท 61% Vol 1.25ฮฒ ยท 61% Vol Lower Realized Risk VOR
Unified Institutional Score Composite Signal 57.8 / 100 (HOLD) 49.0 / 100 (HOLD) Higher Composite VOR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VOR vs VNDA Buy Guide
VOR CONSOLIDATION
52d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live VOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VNDA BREAKDOWN
174d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 75th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live VNDA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VOR nor VNDA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.